CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $25,000 | -13.8% | 14,370 | -2.6% | 0.02% | -10.5% |
| Q2 2016 | $29,000 | -32.6% | 14,750 | -3.0% | 0.02% | -36.7% |
| Q1 2016 | $43,000 | -14.0% | 15,200 | 0.0% | 0.03% | -6.2% |
| Q4 2015 | $50,000 | -68.2% | 15,200 | -24.1% | 0.03% | -68.9% |
| Q3 2015 | $157,000 | -34.3% | 20,030 | -1.3% | 0.10% | -21.4% |
| Q2 2015 | $239,000 | -46.3% | 20,290 | -64.4% | 0.13% | -45.2% |
| Q1 2015 | $445,000 | +9.9% | 56,950 | -6.1% | 0.24% | -0.4% |
| Q4 2014 | $405,000 | -26.1% | 60,650 | -0.4% | 0.24% | -27.1% |
| Q3 2014 | $548,000 | -24.1% | 60,910 | -4.6% | 0.33% | -22.0% |
| Q2 2014 | $722,000 | -30.3% | 63,860 | -7.0% | 0.42% | -24.9% |
| Q1 2014 | $1,036,000 | -21.6% | 68,685 | -28.3% | 0.56% | -29.8% |
| Q4 2013 | $1,321,000 | -11.2% | 95,830 | +30.6% | 0.80% | -15.0% |
| Q3 2013 | $1,487,000 | – | 73,400 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 581,200 | $1,157,000 | 1.33% |
| Fairbanks Capital Management, Inc. | 233,170 | $464,000 | 0.56% |
| DIKER MANAGEMENT LLC | 29,815 | $59,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 199,580 | $397,000 | 0.02% |
| Sterneck Capital Management, LLC | 14,750 | $29,000 | 0.02% |
| Spot Trading L.L.C | 151,900 | $302,000 | 0.01% |
| Acrospire Investment Management LLC | 3,514 | $7,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 84,320 | $168,000 | 0.01% |
| BECK MACK & OLIVER LLC | 18,225 | $36,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 47,600 | $94,000 | 0.00% |